Sign in
Not yet taking people in United StatesNo phase

Testing prompts in emergency departments to guide CT scan ordering for pulmonary embolism

Tests a computer decision tool with nudges for pulmonary embolism CT ordering in emergency departments.

Key facts

Who runs it
NYU Langone Health
Where
Houston, Manhasset, and New York, United StatesSee the 3 sites
Trial code
Registry title
Nudging Provider Adoption of Clinical Decision Support: Implementation of an EHR-Agnostic Pulmonary Embolism Risk Prediction Tool
Status
Not yet recruiting
People taking part
440 people, planned
Started
15 Feb 2026
Expected to end
31 Mar 2029
Type of study
Interventional
Treatments tested
  • Clinical Decision Support (CDS) tool with Nudges
Record updated
22 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for emergency department doctors, nurse practitioners and physician assistants who order CT scans to check adult patients for pulmonary embolism (a blood clot in the lung). It tests a computer tool with reminders that helps with these CT orders.

Age
18 years or older
Sex
All

Main reasons for not taking part

  • Providers who do not work at the study sites: the emergency departments of Northwell Health - Feinstein Institute for Medical Research, Baylor College of Medicine and NYU Langone Health

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • 18 years of older
  • A provider (MD, NP, PA) ordering CTs for evaluation of PE in adult patients present at study site Emergency Department (i.e., Northwell Health - Feinstein Institute for Medical Research, Baylor College of Medicine and NYU Langone Health)

Who cannot take part

  • A provider not present at the specified study sites

Where in United States

  • Baylor College of MedicineHouston, United StatesContact: Natalie HenningNot yet recruiting
  • Northwell Health - Feinstein Institute for Medical ResearchManhasset, United StatesContact: Natalie HenningNot yet recruiting
  • NYU Langone HealthNew York, United StatesContact: Natalie HenningNot yet recruiting

About the trial

What the trial wants to find out

The purpose of this study is to examine the impact of the nudge implementation strategy (CDS tool + Nudge) on adoption of guideline-concordant CT ordering for pulmonary embolism (PE) in 10 EDs. The study will be a 33-month, rigorous, pragmatic, cluster-randomized, stepped wedge trial across 3 health systems and 10 EDs after collecting pre-implementation baseline data. The aim is to to demonstrate technological feasibility as well as examine efficacy of the nudges on adoption. The secondary objective is to decrease CT-ordering when it is not indicated.

The group in the trial

  • Emergency Department (ED) ProvidersTreatment being tested

    Each ED will serve as its own control. Baseline data will be collected for 12 months prior to the implementation of the CDS system with nudges. The CDS tool with nudges will then be implemented for 33 months.

    Treatment: Clinical Decision Support (CDS) tool with Nudges

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Nudging Provider Adoption of Clinical Decision Support: Implementation of an EHR-Agnostic Pulmonary Embolism Risk Prediction Tool
Plain-language title
Testing prompts in emergency departments to guide CT scan ordering for pulmonary embolismGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Publications
Record updated
22 January 2026